Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Clinical data presented for Avax's autologous cancer vaccines

Oct. 29, 1999

Vical receives orphan drug status for Allovectin-7

Oct. 28, 1999

StessGen begins trial of HspE7 for anal dysplasia

Oct. 27, 1999

Development of OvaRex is now sole focus for AltaRex

Oct. 26, 1999

Human trials initiated for IL-13 cytotoxin under development by NeoPharm

Oct. 20, 1999

AltaRex reports new partnering plans for OvaRex MAb

Oct. 19, 1999

ImmunoGen presents positive pharmacokinetic data for huC242-DM1/SB-408075

Oct. 19, 1999

Neurocrine Biosciences' NBI-3001 granted fast track designation

Oct. 18, 1999

Immune Response reports data from phase I colon cancer vaccine study

Oct. 18, 1999

Endorex study shows immune response stimulation by ImmTher in human cancer cells

Oct. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...